Glycogen Storage Disease Type II

DBCOND0002595Cardiovascular DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Glycogen Storage Disease Type II is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Pompe Disease · Acid Maltase Deficiency Disease · Glycogenosis 2 · Glycogen Storage Disease Type II (GSD-II) · Acid Maltase Deficiency (AMD)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0009470ICD-10E74.02SNOMED CT190741002MedDRA10036143UMLSC0017921

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
85Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Glycogen Storage Disease Type II share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In